Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-798
Closed -$257K 63
2024
Q3
$257K Sell
798
-27
-3% -$8.83K 0.2% 53
2024
Q2
$258K Sell
825
-1,833
-69% -$538K 0.2% 60
2024
Q1
$756K Sell
2,658
-1,335
-33% -$391K 0.47% 41
2023
Q4
$1.15M Buy
+3,993
New +$1.09M 0.7% 29

Other funds holding AMGN

Eight 31 Financial's AMGN Position: Q4 2024 in Review

Eight 31 Financial sold out of Amgen (AMGN) in Q4 2024, closing a stake of 798 shares — an estimated $257K sold.

Eight 31 Financial first reported a position in AMGN in Q4 2023 and held it in 4 quarters. The position peaked at $1.15M in Q4 2023. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Eight 31 Financial reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Eight 31 Financial sold 798 Amgen shares in Q4 2024, an estimated $257K.
  • Eight 31 Financial first reported a position in Amgen in Q4 2023 and held it in 4 quarters.
  • Eight 31 Financial's Amgen position peaked at $1.15M in Q4 2023.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Eight 31 Financial's 13F filing for Q4 2024, filed 14 Feb 2025.